Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

NCT00920153 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

442

Enrollment

OTHER

Sponsor class

Stopped Other new drugs

Conditions

Lymphoma

Interventions

BIOLOGICAL: bleomycin sulfate
DRUG: ABVD regimen
DRUG: carmustine
DRUG: cisplatin
DRUG: cytarabine
DRUG: dacarbazine
DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: gemcitabine hydrochloride
DRUG: ifosfamide
DRUG: melphalan
DRUG: methylprednisolone
DRUG: mitoguazone
DRUG: vincristine sulfate
DRUG: vindesine
DRUG: vinorelbine tartrate
PROCEDURE: allogeneic hematopoietic stem cell transplantation
PROCEDURE: autologous hematopoietic stem cell transplantation

Sponsor

French Innovative Leukemia Organisation